U.S. Markets open in 35 hrs, 45 mins
| Symbol | Value | Change | Percentage Change |
|---|---|---|---|
| DJIA | 11,220.96 | 32.73 | 0.29% |
| NASDAQ | 2,255.88 | -3.16 | -0.14% |
| S&P 500 | 1,242.31 | 5.48 | 0.44% |
| Day Low 08:00 PM EDT | 81.95 | |
|---|---|---|
| Day High 08:00 PM EDT | 83.35 |
|
| Range | 1.40 | |
| Volume | 76,108 | |
| 30-Day Avg. Vol. | — |
|
| Difference | — | |
| Market Cap. | 57.78 B | |
| Change | -140.51 M | |
| Shares Out. | — | |
| Percent Traded | 0.01% | |
| Revenue (LFY) | — | |
| Earnings (TTM) | — | |
| Next Earnings | - |
|
| EPS (TTM) | — |
| 52-Wk Low 5/12/08 | 79.09 | |
|---|---|---|
| 52-Wk High 3/3/08 | 99.00 |
|
| Range | 19.91 | |
| Prev. Close 9/5/08 | 82.45 | |
| Today's Open | — | |
| Change | — | |
| Dividend (TTM) | — | |
| Div. Yield (TTM) | — |
|
| Beta | — | |
| P/E Ratio (TTM) | — | |
| P/E Ratio (Fwd.) | — |
Roche is on a roll. The company operates two segments, pharmaceuticals and diagnostics, and sells its products in more than 150 countries. Roche's prescription drugs include cancer therapies MabThera/Rituxan ... View Full Description
| Earnings/Share(EPS) | Estimate | Actual | Difference |
|---|---|---|---|
| 2 Quarters Ago | — 9/30/06 | — 9/30/06 |
—
—
|
| Last Quarter | 1.90 12/31/06 | 1.85 12/31/06 |
-0.05
Missed
|
| Quarterly - | Annual - | |
|---|---|---|
| Total Revenue | — | — |
| Gross Profit | — | — |
| Operating Income | — | — |
| Net Income | — | — |
